Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 249 Breast Neoplasms 136 Neoplasms 108 Prostatic Neoplasms 35 Fatigue 35 Obesity 25 Lung Neoplasms 24 Colorectal Neoplasms 24 Polycystic Ovary Syndrome 17 Colonic Neoplasms 16 Ovarian Neoplasms 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Pancreatic Neoplasms 11 Lymphoma 11 Lymphedema 11 Hematologic Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Weight Loss 10 Rectal Neoplasms 10 Multiple Myeloma 10 Head and Neck Neoplasms 10 Leukemia 9 Insulin Resistance 8 Cardiotoxicity 8 Brain Neoplasms 8 Stomach Neoplasms 7 Peripheral Nervous System Diseases 7 Overweight 6 Esophageal Neoplasms 6 Cognitive Dysfunction 6

Interventions

Ipilimumab 29 Nivolumab 23 pembrolizumab 14 incomplete Freund's adjuvant 10 Cyclophosphamide 10 Melphalan 9 Interleukin-2 9 CTLA-4 Antigen 8 tebentafusp 7 sargramostim 7 Temozolomide 7 MART-1 Antigen 7 Dacarbazine 7 Ranibizumab 6 montanide ISA 51 5 fludarabine phosphate 5 fludarabine 5 Sunitinib 5 Radiosurgery 5 Carboplatin 5 Blood Specimen Collection 5 Bevacizumab 5 aldesleukin 4 aflibercept 4 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Biopsy 4 trametinib 3 sotrastaurin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Uveal Melanoma × Exercise × Clear all

NCT06970236 2025-05-28

IHOPE

University of Valencia

Phase NA Recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡